Citation Impact

Citing Papers

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
2006
Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes
2012
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Discoveries in structure and physiology of mechanically activated ion channels
2020 StandoutNatureNobel
The sweetness of the DNA backbone drives Toll-like receptor 9
2008
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
2009 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
siRNA and isRNA: two edges of one sword
2006
Genetic analysis of resistance to viral infection
2007 StandoutNobel
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Gestational trophoblastic disease
2010 Standout
ACR Appropriateness Criteria® on Postmastectomy Radiotherapy
2009
Pattern Recognition Receptors and Inflammation
2010 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
2010 StandoutNobel
Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells
2014
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Intracellular Toll-like Receptors
2010 StandoutNobel
Innate immune recognition of, and regulation by, DNA
2006
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions
2005
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
2011
The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
2008
Nanotechnology: Intelligent Design to Treat Complex Disease
2006
Endogenous TLR Ligands and Autoimmunity
2006
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells
2021 StandoutNobel
Survey of the year 2003 commercial optical biosensor literature
2004
Toll-like receptor function and signaling
2006
Metastatic colonization by circulating tumour cells
2016 StandoutNature
NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation
2008
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
2008 StandoutNature
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
2020
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
2007
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
2016 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
2018
Production of type I interferons
2005
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Particle size and activation threshold: a new dimension of danger signaling
2010
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
2011 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila
2010 StandoutNobel
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Targeting claudins in cancer: diagnosis, prognosis and therapy.
2021
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
5'-Triphosphate RNA Is the Ligand for RIG-I
2006 StandoutScience
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout

Works of C. Richter being referenced

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer
2010
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody
2010
The α‐helix of the second chromodomain of the 43 kDa subunit of the chloroplast signal recognition particle facilitates binding to the 54 kDa subunit
2006
Spontaneous Formation of Nucleic Acid-based Nanoparticles Is Responsible for High Interferon-α Induction by CpG-A in Plasmacytoid Dendritic Cells
2005
Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia
2005
Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles
2006
Oxygenierungsstatus von Plattenepithelkarzinomen der Kopf-Hals-Region
1998
2014 Acute normal tissue reaction and local control in breast cancer patients with postmastectomy radiotherapy
1996
The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand
2012
Rankless by CCL
2026